Full history for every metric is available with a Kvantra account
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 968 | 1,060 | 1,204 | 1,799 | 2,371 | 2,941 | 3,217 | 3,455 |
| Operating profit | €m | -23.8 | -10.2 | ||||||
| Net profit | €m | -16.8 | -74.2 | -77.6 | -12.0 | -45.5 | -37.7 | -42.0 | -7.4 |
| EPS reported | € | -1.87 | -2.09 | ||||||
| Operating cashflow per share | € | 1.14 | -0.57 | ||||||
| Capex per share | € | 3.94 | 4.28 | ||||||
| FCF per share | € | -2.80 | -4.85 | ||||||
| Free cash flow | €m | -56.3 | -97.6 | ||||||
| Net debt | €m | 145 | 236 | ||||||
| Book value equity | €m | 459 | 457 | ||||||
| Book value per share | € | 22.84 | 22.74 | ||||||
| Number of shares | m | 20.11 | 20.11 | ||||||
| DPS (TTM paid) | € | 0.00 | 0.00 |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 2.85 | 3.10 | ||||||
| P/S LTM | x | 0.45 | 0.44 | ||||||
| P/FCF LTM | x | -23.25 | -14.52 | ||||||
| EV/EBITDA LTM | x | 35.80 | 24.32 | ||||||
| EV/Sales LTM | x | 0.56 | 0.51 | ||||||
| Earnings Yield LTM | % | -2.88% | -2.98% | ||||||
| FCF Yield | % | -4.30% | -6.89% | ||||||
| Quality | |||||||||
| ROE | % | -8.21% | -9.00% | ||||||
| ROIC | % | -2.11% | -1.21% | ||||||
| Operating margin | % | -0.81% | -0.32% | ||||||
| Gross margin | % | 20.19% | 20.27% | ||||||
| FCF/Sales | % | -1.91% | -3.03% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +24.06% | +20.23% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | 0.00% | 0.00% | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.14 | -0.28 | ||||||
| Net Debt/EBITDA | x | 7.09 | 4.09 | ||||||
| EBIT/Net interest | x | -1.17 | -0.53 | ||||||
| Net debt/market cap | % | 11.05% | 16.63% | ||||||
| Net debt/Equity | x | 0.32 | 0.52 | ||||||
| Gross debt/equity | x | 0.91 | 0.78 | ||||||
ETFs that hold Redcare Pharmacy
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| Amundi SDAX UCITS ETF Dist | C005.DE | 2 | 3.06% |
Funds with Redcare Pharmacy among their ten largest holdings, largest fund first.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Redcare Pharmacy N.V. manages and runs a network of digital pharmacies across Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. The company offers a comprehensive selection of healthcare products, including prescription medications, over-the-counter drugs, pharmacy-related beauty and personal care items, and nutritional supplements. Established in 2001, the firm, initially known as Shop Apotheke Europe N.V., officially rebranded to Redcare Pharmacy N.V. in June 2023. Its operational headquarters are situated in Sevenum, the Netherlands.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| Amundi SDAX UCITS ETF Dist | C005.DE | 2 | 3.06% |
Funds with Redcare Pharmacy among their ten largest holdings, largest fund first.
Based on consensus from external analysts. Not Kvantra's opinion.
Redcare Pharmacy N.V. manages and runs a network of digital pharmacies across Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. The company offers a comprehensive selection of healthcare products, including prescription medications, over-the-counter drugs, pharmacy-related beauty and personal care items, and nutritional supplements. Established in 2001, the firm, initially known as Shop Apotheke Europe N.V., officially rebranded to Redcare Pharmacy N.V. in June 2023. Its operational headquarters are situated in Sevenum, the Netherlands.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free